Clinical Trials Logo

Clinical Trial Summary

This study aims to evaluate the safety of intramuscular (IM) administration of PLX-R18 in subjects with incomplete hematopoietic recovery following HCT.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

  • Incomplete HCT (Hematopoietic Cell Transplantation)

NCT number NCT03002519
Study type Interventional
Source Pluristem Ltd.
Status Active, not recruiting
Phase Phase 1
Start date February 8, 2017
Completion date October 2021